XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Income - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Condensed Consolidated Statements of Income [Abstract]        
Net sales $ 122,568,000 $ 125,574,000 $ 372,654,000 $ 385,096,000
Cost of goods sold 98,327,000 97,913,000 295,300,000 303,279,000
Gross profit 24,241,000 27,661,000 77,354,000 81,817,000
Operating expenses:        
General and administrative 14,005,000 14,390,000 38,210,000 39,410,000
Sales and marketing 4,698,000 5,623,000 13,224,000 15,990,000
Research and development 2,100,000 2,174,000 6,014,000 6,694,000
Foreign exchange impact of lease liabilities and forward contracts (12,455,000) (3,772,000) (21,257,000) (2,507,000)
Total operating expenses 8,348,000 18,415,000 36,191,000 59,587,000
Operating income 15,893,000 9,246,000 41,163,000 22,230,000
Interest expense, net 4,051,000 6,879,000 12,074,000 19,575,000
Income before income tax expense 11,842,000 2,367,000 29,089,000 2,655,000
Income tax expense 3,373,000 1,502,000 8,448,000 1,752,000
Net income $ 8,469,000 $ 865,000 $ 20,641,000 $ 903,000
Basic net income per share (in dollars per share) $ 0.44 $ 0.05 $ 1.09 $ 0.05
Diluted net income per share (in dollars per share) $ 0.44 $ 0.04 $ 1.07 $ 0.05
Weighted average number of shares outstanding:        
Basic (in shares) 19,053,232 18,961,517 19,016,302 18,895,893
Diluted (in shares) 19,436,793 19,305,805 19,333,758 19,263,114